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Diminished motivation is associated with robust impairment in 
psychosocial functioning in schizophrenia (SZ). Little is known 
about the reciprocal relationships between motivation and func-
tioning, particularly following a first episode of psychosis. We 
tested bidirectional associations between motivation and social 
and occupational functioning in the year following a first epi-
sode of SZ spectrum disorder among patients in the Recovery 
After an Initial Schizophrenia Episode—Early Treatment 
Program (RAISE-ETP) study. Four hundred four individuals 
(aged 15–40) who presented with a first episode of SZ spec-
trum disorder (eg, SZ, schizoaffective or schizophreniform 
disorder, psychotic disorder not otherwise specified) completed 
assessments of work and school functioning, social functioning, 
and motivation at 6- and 12-month follow-up, controlling for 
assessments at study entry. Controlling for cognition, and psy-
chotic and depressive symptoms measured at each time point, 
motivation at 6 months was associated with work and school 
participation at 12 months, but work and school participation 
at 6 months was not associated with motivation at 12 months. 
Conversely, social functioning at 6 months was associated 
with motivation at 12 months, but motivation at 6 months was 
not associated with social functioning at 12 months. Findings 
suggest that motivation is associated with later occupational, 
but not social, functioning in the first year following an initial 
episode of psychosis. Social functioning, on the other hand, 
is associated with later motivation. Future intervention trials 
focused on improving occupational functioning in this popula-
tion may benefit from targeting patient motivation directly (eg, 
through motivational interviewing), or indirectly by improving 
relationships and support networks.
Key words:  motivation/psychosocial functioning/first 
episode psychosis/schizophrenia/cross-lagged analysis
Introduction
Impairments in motivation and psychosocial function-
ing (ie, occupational and social functioning) are cardi-
nal features of schizophrenia (SZ) spectrum disorders. 
These impairments precede the onset of disorder,1,2 per-
sist over the long-term course,3,4 and present a challenge 
to treatment.5,6 Motivation is a complex construct that 
has received renewed interest in the context of negative 
symptoms in SZ.7,8 Negative symptoms have been empiri-
cally divided into expressive and experiential domains.7,9 
Expressive symptoms consist of affective flattening and 
alogia, while experiential symptoms are characterized 
by anhedonia, reduced social drive, and amotivation.7 
Amotivation, in particular, shows robust association 
with psychosocial functioning impairments in SZ.10,11 In 
general models of motivation, deficits in “liking” (ie, in-
the-moment pleasure) appear to be more associated with 
anhedonia, or diminished interest/pleasure, while defi-
cits in “wanting” (ie, anticipation of pleasure and asso-
ciated drive) tend to be more associated with deficits in 
motivated behavior.12,13 Deficits in “wanting,” which are 
associated with mesolimbic dopaminergic transmission 
in animal models, have been identified as key contribu-
tors to amotivation and associated impairments in goal-
directed behavior in SZ.14
When motivation and functioning are measured con-
currently, as much as 50%–75% of the variance is shared 
between them.15–17 Much of this shared variance may 
be due to item overlap in the measures typically used to 
assess amotivation within the context of negative symp-
toms broadly defined. The Scale for the Assessment of 
Negative Symptoms (SANS18), for example, includes 
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questions covering impersistence at work or school as a 
key indicator of avolition/apathy. Those not participat-
ing in work or school will receive a higher score on this 
scale, conflating the two constructs. Only more recently 
has there been a movement in the field to develop nega-
tive symptom measures that more specifically assess expe-
riential symptoms, including amotivation.19,20 Thus, most 
of what we currently know about the connection between 
motivation and functioning is derived from studies using 
less sensitive assessments of negative symptoms. In addi-
tion, reduced functioning is undoubtedly driven by a mul-
titude of factors in SZ, such as cognitive impairment21,22 
and positive,23,24 negative,2,25 and depressive2,26 symptoms. 
The disruptive effects of psychotic episodes and hospital-
izations could also impair functioning through demoral-
ization and, relatedly, reduced motivation.27
While standard measures of negative symptoms often 
fail to capture amotivation specifically, items from the 
Quality of Life Scale (QLS28)—motivation, sense of pur-
pose, and curiosity—have shown consistent associations 
with goal-directed behavior and psychosocial function-
ing in SZ.25,27 These items also demonstrate convergent 
validity in their association with avolition as measured 
by the Schedule for the Deficit Syndrome (SDS29),30 an 
instrument originally developed to identify patients with 
primary negative symptom-based deficits, including a 
reduced sense of purpose and social drive.
Given the lack of examination of the reciprocal asso-
ciations over time in studies of first episode SZ, it is dif-
ficult to infer the relative primacy of these constructs. 
In addition, the tendency to combine occupational and 
social functioning into a single outcome precludes evalu-
ation of the potential for differential associations with 
motivation.
To address these questions, in the current study we 
examined the prospective, reciprocal associations between 
motivation and social and occupational functioning in a 
large sample of patients following a first episode of SZ. 
Because social and occupational functioning are only 
moderately correlated in SZ,31,32 we examined these vari-
ables separately. We conducted cross-lagged panel analy-
sis using structural equation modeling to examine (a) 
whether motivation following an initial episode of SZ 
was associated with subsequent occupational and social 
functioning, (b) whether psychosocial functioning was 
associated with later levels of motivation, or (c) both. 
Because longitudinal evidence suggests motivation can 
influence functioning and vice versa, we explored the 
extent to which the two domains of functioning showed 
reciprocal associations with motivation over time.
Methods
Participants
Participants were part of the longitudinal multisite 
National Institute of Mental Health’s (NIMH) Recovery 
After an Initial Schizophrenia Episode—Early Treatment 
Program (RAISE-ETP).33 RAISE-ETP was a cluster-
randomized clinical trial that compared a comprehen-
sive intervention for first episode SZ to usual community 
care. Four hundred four participants between the ages 
of 15 and 40 were recruited across 34 community mental 
health treatment centers in 21 states and were followed 
up for a minimum of 2  years. All participants received 
intervention lasting up to 2  years. Individuals were eli-
gible if  they had one of the following DSM-IV diag-
noses: SZ, schizoaffective disorder, schizophreniform 
disorder, brief  psychotic disorder, or psychotic disorder 
not otherwise specified. Individuals with clinically sig-
nificant head trauma or other serious medical conditions 
were excluded. All participants had experienced only a 
single episode of psychosis and had ≤6  months of life-
time antipsychotic medication treatment. All participants 
provided written informed consent (as well as assent and 
parental/guardian consent for those under 18 years old). 
A more detailed description of recruitment procedures, 
clinical site selection and randomization, treatment com-
ponents and outcomes is provided elsewhere.33–35
Measures
Descriptive statistics of the sample and variables of 
interest are provided in table 1. Diagnostic and assess-
ment interviews were conducted using 2-way video con-
ferencing completed by remote, centralized personnel 
(ie, individuals with training to provide research quality 
interviews who were blind to study design and assign-
ment). One interviewer conducted all the assessments for 
a given participant at a given time point, but each partici-
pant could be assessed by different raters at different time 
points across the study. The following assessments rele-
vant to the current report were conducted by the raters: 
the Structured Clinical Interview for DSM-IV (SCID)36 to 
determine psychiatric diagnoses; the Positive and Negative 
Syndrome Scale (PANSS)37 to assess psychotic symptoms; 
the Calgary Depression Scale for Schizophrenia (CDSS)38 
to assess symptoms of depression; and the Quality of Life 
Scale (QLS).37 The QLS is a 21-item scale that assesses 
qualities such as motivation, social interaction, and 
engagement in life roles and activities over the past month. 
Each QLS item is rated on a scale ranging from 0 to 6 with 
lower scores indicating more severe impairment. The scale 
is subdivided into the following 4 subscales: Intrapsychic 
Foundations, Interpersonal Relations, Instrumental Role 
Functioning, and Common Objects and Activities. The 
QLS, PANSS, and CDSS were completed every 6 months. 
Site-based personnel completed the following assess-
ments: Brief Assessment of Cognition in Schizophrenia 
(BACS),39 that includes tests of verbal memory, digit 
sequencing, token motor, verbal fluency, symbol coding, 
and tower of London; the Services Utilization Recording 
Form (SURF),40 a questionnaire that documents health 
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care services and indices of community participation (eg, 
work or school) present in the past month. The BACS was 
completed at baseline, 1-year and 2-year assessments, and 
the SURF was completed monthly.
Motivation. Our measure of motivation was based on 
3 items of the Intrapsychic Foundations subscale of the 
QLS, including degree of motivation, sense of purpose, 
and curiosity. Example questions include “Have you had 
much enthusiasm, energy and drive?”, “Have you set any 
goals for yourself ?”, and “How often have you seen or 
heard about something that you wanted to know more 
about or understand better?” These items have been used 
as an index of general motivation in various studies of 
people with SZ.17,27,41 In a recent factor analysis of the 
QLS, these 3 items loaded most strongly on the subscale.42
Social Functioning. Social functioning was derived from 
the Interpersonal Relations subscale of the QLS. We used 
7 items from the full scale: intimate interactions, active 
acquaintances, social activity, involved social network, 
social initiatives, social withdrawal, and socio-sexual rela-
tions. These items capture the multifaceted nature of social 
relationships, including the quantity (eg, “How many friends 
do you have”) and quality (eg, “Do you have friends with 
whom you are especially close other than your immediate 
family or the people you live with?”) of these relationships.
Occupational Functioning. Three items from the SURF 
(ie, Are you currently a student? Have you worked for pay 
during the past 30 days? Have you done any casual work or 
day jobs, such as yard work or babysitting for which you got 
paid?) were combined into a single score to measure work 
or school functioning at each assessment point (ie, the past 
month) and aggregated across 6-month time points; each 
was rated as either 0 = no (ie, no paid work and not a stu-
dent) or 1 = yes (ie, paid work or a student). The goal of the 
current study was to examine the extent to which motiva-
tion at one point in time predicted involvement in work or 
school at a later time point (and vice versa), as these are the 
roles of greatest concern in young people who have recently 
developed SZ. Therefore, the SURF composite score was 
used to measure work or school involvement, rather than 
the more generic Instrumental Role Functioning subscale 
of the QLS, which focuses on functioning in the “home-
maker” role for participants who are not “attempting” the 
role of student or worker.
Covariates. Psychotic symptom ratings were based on a 
Positive Symptom Factor Score of the following PANSS 
items: delusions, hallucinations, grandiosity, and unusual 
thought content.43 Depression was calculated based on a 
total score on the CDSS. A composite score of cognitive 
functioning was created by computing the average of the 
six BACS tests; baseline and 12-month BACS scores were 
averaged in the current study to provide a stable indicator 
of cognitive ability; this was done because there was some 
evidence that cognitive functioning varied within partici-
pants from baseline to 12-month follow-up. We used sub-
scale averages, as opposed to normed scores, as we were 
primarily interested in variance in motivation and psy-
chosocial functioning accounted for by cognitive ability.
Although our focus in the current report is on moti-
vation and social functioning, the QLS was originally 
designed to assess the multifaceted nature of intra- and 
interpersonal features of SZ. As such, although the 
PANSS also assesses negative symptoms, we did not 
include these items in the current analysis given their 
overlap with the QLS (correlations in the current sam-
ple range from .62 to .73) and the inclusion of symptoms 
in the PANSS that are less robustly related to function-
ing (eg, blunted affect).11 (Because of the possibility of 
associations between expressive negative symptoms and 
psychosocial functioning, we tested the bivariate asso-
ciations between blunted affect on the PANSS and our 
measures of psychosocial functioning (SURF work/
school and QLS interpersonal relations). Associations 
Table 1. Study Sample Characteristics and Variable Descriptive 
Statistics
Mean (SD) or %
Demographics
 Age 23.14 (5.07)
 Gender: male 72.5%
 Race
  American Indian or Alaskan Native 5.2%
  Asian 3.0%
  Black or African American 37.6%
   Native Hawaiian or Other Pacific 
Islander
0.2%
  White 54.0%
   Ethnicity: Hispanic or Latino 18.1%
Outcome variablesa
 SURF work or school baseline 39.8%
 SURF work or school 6 mo 71.8%
 SURF work or school 12 mo 66.6%
 QLS motivation baseline 7.61 (3.52)
 QLS motivation 6 mo 8.52 (3.64)
 QLS motivation 12 mo 8.31 (3.69)
  QLS interpersonal relationships 
baseline
19.76 (8.70)
 QLS interpersonal relationships 6 mo 22.88 (9.76)
 QLS interpersonal relationships 12 mo 23.65 (9.51)
 PANSS positive symptoms baseline 12.24 (3.83)
 PANSS positive symptoms 6 mo 10.04 (4.18)
 PANSS positive symptoms 12 mo 10.04 (3.74)
 CDSS baseline 4.65 (4.28)
 CDSS 6 mo 3.70 (4.33)
 CDSS 12 mo 2.61 (3.52)
 BACS baseline/12 mo 37.38 (7.02)
Note: BACS, Brief  Assessment of Cognition in Schizophrenia; 
CDSS, Calgary Depression Scale for Schizophrenia; PANSS, 
Positive and Negative Syndrome Scale; QLS, Quality of Life 
Scale; SURF, Service Utilization Recording Form; mo, months.
aNs range from 257 (12 mo) to 404 (baseline).
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between blunted affect and work/school participation 
were small and nonsignificant at all time points (−0.05 
to −0.10). Correlations between blunted affect and social 
functioning, however, ranged from −0.19 to −0.30. While 
these are modest associations, we included blunted affect 
as a covariate at baseline, 6, and 12 months in the pri-
mary model testing the association of motivation and 
social functioning. The inclusion of blunted affect did 
not change the primary findings.)
Statistical Analyses
Before testing multivariate models, we examined the bivar-
iate correlations among variables of interest across the 
3 primary time points (baseline, 6-months, 12-months). 
We used structural equation modeling (SEM) to evaluate 
our primary research question, examining occupational 
and social functioning in separate models. We employed 
cross-lagged panel analysis to identify the degree to which 
motivation predicted functioning, and/or functioning 
predicted motivation, while controlling for previous and 
concurrent measurements of each variable (and other 
covariates). Models were tested in sequence, beginning 
with the autoregressive model (eg, motivation at 6 months 
predicting motivation at 12 months), then testing each 
directional model (eg, motivation at 6 months predict-
ing occupational functioning at 12 months). We allowed 
residuals of the same variables measured across time to 
covary so as to minimize the impact of multicollinearity. 
In the case in which both directional associations were 
significant, fully cross-lagged models were tested, includ-
ing the autoregressive and directional models simultane-
ously. Given the known associations among cognition, 
psychotic symptoms, and depression with motivation and 
psychosocial functioning, we included these variables as 
covariates in initial models. Ratings of symptoms of psy-
chosis and depression at study entry (baseline), 6 months, 
and 12 months, and tests of cognition aggregated across 
baseline and 12 months, were included as covariates in 
these models. Path coefficients with P values >.15 were 
set to 0 in subsequent models.
These data were from a treatment trial of first-epi-
sode psychosis in which participants entering the trial 
had recently experienced an initial psychotic episode. 
Seventy-eight percent of participants had been hospital-
ized before study entry (median number of weeks since 
last hospitalization  =  8). In addition, the primary out-
comes of RAISE-ETP suggested that the most significant 
improvements in psychosocial functioning occurred by 
the 6-month time point.34 Thus, to minimize the influ-
ence of symptom variance on the relationships between 
the variables of interest, we set the 6-month time point 
as the baseline, using the true baseline time point (ie, 
Month 0)  for motivation and psychosocial functioning 
as control variables in all models. The treatment group 
was included as a moderating variable to examine the 
impact of intervention on the variables of interest. We 
also accounted for clustering of observations by site. To 
examine the stability of associations over a longer period 
of time, we conducted sensitivity analyses aggregating the 
12- and 18-month time points of the outcomes of interest 
among our primary models.
Model fit was assessed using standard criteria, includ-
ing the χ2 test, root mean square error of approximation 
(RMSEA), comparative fit index (CFI), and Tucker–
Lewis index (TLI). For models with categorical outcomes, 
we compared fit using robust weighted least squares 
estimation. For models using continuous outcomes, we 
utilized χ2 difference tests. Standardized coefficients are 
presented, and 2-tailed P values <.05 were considered 
statistically significant. Analyses were performed using 
Mplus version 7.4.
Results
Missing data due to treatment study dropout ranged 
from 0% (SURF) to 28% (QLS) at 6 months, and 21% 
(SURF) to 36% (QLS) at 12 months. Those who did not 
have follow-up data did not differ in the primary meas-
ures of interest at baseline from those who had follow-up 
data. Missing data were handled in the models using full 
information maximum likelihood. Bivariate correlations 
revealed significant associations among our primary 
variables of interest (supplementary table 1). Cognition 
(BACS) was unrelated to psychotic (PANSS positive 
symptoms) and depressive (CDSS) symptoms at all time 
points.
In preliminary SEM analyses, treatment group, dura-
tion of untreated psychosis, gender, age, or ethnicity did 
not moderate the associations between motivation and 
psychosocial functioning, so we did not include these 
variables in the models presented below. As predicted, 
cognition at baseline, and psychotic and depressive symp-
toms at corresponding time points were significantly 
associated with motivation and social and occupational 
functioning and were thus included as covariates in the 
models. See supplementary tables for BACS, PANSS, and 
CDSS coefficients.
Motivation and Occupational Functioning
We first tested the autoregressive model, examining the 
stability of motivation and occupational functioning 
across baseline, 6, and 12 months. The model provided 
adequate fit to the data (χ2 (43)  =  54.734, P  =  .108; 
RMSEA  =  0.026; CFI  =  0.994; TLI  =  0.989). Next, 
we tested the model including motivation at 6  months 
as predictor of occupational functioning at 12  months, 
controlling for baseline assessments. Adding this path 
resulted in improved model fit (χ2 (41) = 49.979, P = .159; 
RMSEA = 0.023; CFI = 0.995; TLI = 0.991), though the 
degree of improvement was at a trend level of significance 
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(χ2 (2) = 5.328, P =  .069). Motivation at 6 months was 
significantly associated with occupational functioning at 
12 months (β = 0.190, SE = 0.062, P =  .002). We then 
tested the directional model in which occupational func-
tioning at 6  months was associated with motivation at 
12 months. Freeing this parameter resulted in adequate 
model fit (χ2 (41) = 53.928, P = .085; RMSEA = 0.028; 
CFI = 0.993; TLI = 0.988), but did not improve fit from 
the baseline model (χ2 (2) = 0.133, P = .936). Importantly, 
occupational functioning at 6 months was not associated 
with motivation at 12  months (β  =  0.036, SE  =  0.066, 
P =  .578). Because this directional path was not signif-
icant, and model fit was not improved, we did not test 
the fully cross-lagged model with motivation and occupa-
tional functioning reciprocally linked. We therefore con-
cluded that motivation at 6 months more likely influenced 
occupational functioning at 12 months than the reverse 
(figure 1).
Motivation and Social Functioning
The autoregressive model provided adequate fit to 
the data (χ2 (41) = 60.000, P =  .028; RMSEA = 0.034; 
CFI = 0.980; TLI = 0.966). The model including moti-
vation at 6  months as a correlate of social function-
ing at 12  months, controlling for baseline assessments, 
resulted in adequate fit (χ2 (39)  =  59.404, P  =  .019; 
RMSEA  =  0.036; CFI  =  0.978; TLI  =  0.962); how-
ever, motivation at 6  months was not associated with 
social functioning at 12 months (β = 0.001, SE = 0.020, 
P  =  .994). The directional model in which social func-
tioning at 6  months was associated with motivation at 
12 months resulted in adequate model fit (χ2 (39) = 50.823, 
P = .097; RMSEA = 0.027; CFI = 0.987; TLI = 0.978), 
and there was a significant improvement in fit from the 
baseline model (χ2 (2)  =  8.508, P < .001). Importantly, 
social functioning at 6 months was associated with moti-
vation at 12 months (β = 0.497, SE = 0.195, P =  .011). 
Because only this directional path was significant, we 
did not test the fully cross-lagged model with motivation 
and social functioning reciprocally linked. We therefore 
concluded that social functioning at 6 months was more 
likely to influence 12-month motivation than motivation 
at 6 months was to influence 12-month social functioning 
(figure 2).
Sensitivity Analysis
To evaluate the stability of these associations over a longer 
period of time, we tested the above models after aggre-
gating outcome variables across the 12- and 18-month 
assessments. As opposed to conducting an independent 
evaluation of the 18-month time point, we aggregated 
these waves because missing data limited our power to 
test that model. These tests revealed that the primary 
relationships held through the 18-month time point: 
coefficients were comparable in effect size, and model fit 
indices were good and similar to the more constrained 
models. Findings from these analyses are presented in 
supplementary tables 4 and 5.
Discussion
In a large sample of patients with a first episode of psy-
chosis drawn from 34 clinics across 21 states, motivation 
was associated with later occupational functioning, but 
occupational functioning was not associated with later 
motivation. The opposite association was found for the 
social domain: social functioning was associated with 
later motivation, but motivation was not associated with 
later social functioning. The associations were examined 
in participants after 6 months of treatment, control-
ling for baseline levels of these variables, and therefore 
likely reflect stable relationships that are less influenced 
by the immediate aftermath of a first episode of psycho-
sis. Furthermore, the relationships were replicated in sen-
sitivity analyses aggregating the 12- and 18-month time 
points, supporting the reliability of the main findings. 
The findings were also robust to important covariates, 
including demographic variables such as age, gender, and 
ethnicity, as well as treatment assignment.
Consistent with previous studies, findings suggest that 
motivation, as reflected by activation, drive, and goal 
Fig. 1. Cross-lagged associations between motivation (Quality of Life Scale motivation, sense of purpose, and curiosity) and 
occupational functioning/work or school (Services Utilization Recording Form). ***P < .001, **P < .01, *P < .05. Covariates include 
depression (CDSS) and psychotic symptoms (PANSS positive) at each time point, and cognition (BACS)—baseline and 12-month 
average. Unidirectional arrows indicate standardized regression coefficients; bidirectional arrows indicate covariances. Residuals of the 
autoregressive associations were allowed to covary.
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engagement, is especially critical to occupational func-
tioning in young individuals who have recently developed 
a psychotic illness.44 Such motivation in the occupational 
domain may be reflected by individuals identifying work 
or school goals, independently completing job or school 
re-enrollment applications, or actively seeking vocational 
and educational services. That levels of motivation were 
associated with work and school functioning, but not 
social functioning, was unexpected. While other factors 
such as cognition, interpersonal skills, and symptoms 
may also play a role in success at work or school, their 
importance may be secondary to the motivation to pur-
sue engagement in those roles. Consistent with this idea, 
reported desire for work and active efforts to find work 
are strong predictors of competitive employment up to 
2 years later in people with SZ.45
Motivation was not associated with later social func-
tioning; however, other variables not measured in this 
study may be more predictive of success in this domain, 
such as social skills/capacity, social support, and social 
cognition.16,46,47 While several studies have suggested that 
negative symptoms, including motivation, are associated 
cross-sectionally with social functioning, there is less evi-
dence that motivation predicts social functioning over 
time.44,46,48,49 Social functioning may be more dependent 
on the acquisition of specific skills than is participation 
in work or school. Therefore, in the relative absence of 
concerted opportunities to learn social skills, motivation 
may be more strongly related to work or school participa-
tion. In addition, social skills training improves both neg-
ative symptoms and social functioning in SZ,50 but has 
less impact on occupational functioning.51–53 As such, tar-
geting receptive and expressive social skills may be more 
fruitful than targeting motivation for patients who report 
a desire to improve social relationships.
So why was social functioning associated with later 
motivation? Higher levels of social engagement and 
closer relationships may play a protective role in main-
taining motivation in SZ, especially early on in the illness. 
Regular involvement in the lives of others and reciprocal 
relationships may provide important social validation and 
acceptance that facilitates the rebuilding of confidence, 
self-esteem, and sense of purpose after the devastating 
effects of a psychotic episode.54 Close and rewarding rela-
tionships may, in turn, support the articulation and pur-
suit of personal goals. Indeed, ample evidence suggests 
that the presence of relationships and degree of social sup-
port have lasting positive effects on the course of SZ.55,56 
We are aware of one other prospective study examining 
reciprocal associations between motivation and psycho-
social functioning in patients with SZ.27 Nakagami et al 
reported that across a 1-year period in patients receiving 
community-based rehabilitative services, baseline psycho-
social functioning predicted changes in motivation, while 
baseline motivation did not predict changes in function-
ing. We note, however, that in this study the sample was 
multi-episode SZ, and social and occupational function-
ing were combined into one outcome, precluding interpre-
tation of differential outcomes.
While the QLS motivation items are strongly tied to 
other measures of amotivation/avolition,29,30 and have 
shown robust associations with psychosocial functioning 
in several studies,25,27 it is important to note that there are 
newer rating scales available that provide more compre-
hensive coverage of the multifaceted nature of experien-
tial negative symptoms in SZ, including the assessment of 
motivation and pleasure across social, occupational, and 
recreational domains. The inclusion of scales such as the 
Clinical Assessment Interview for Negative Symptoms 
(CAINS19) or Brief  Negative Symptom Scale (BNSS20), 
for example, could improve our understanding of which 
qualities of experiential negative symptoms might be 
most critical for understanding psychosocial functioning 
over time. In addition, the inclusion of behavioral meas-
ures translated from animal models, such as those assess-
ing effort-based decision-making (eg, Effort Expenditure 
for Rewards Task; EEfRT57,58), could improve prediction 
of important psychosocial functioning outcomes in SZ. 
Finally, future studies should model relative changes in 
motivation and psychosocial functioning (eg, using latent 
growth curve modeling) to improve understanding of the 
associations of these constructs within people over time.
Fig. 2. Cross-lagged associations between motivation (Quality of Life Scale [QLS] motivation, sense of purpose, and curiosity) and 
social functioning (QLS interpersonal relations). ***P < .001, **P < .01, *P < .05. Covariates include depression (CDSS) and psychotic 
symptoms (PANSS positive) at each time point, and cognition (BACS)—baseline and 12-month average. Unidirectional arrows indicate 
standardized regression coefficients; bidirectional arrows indicate covariances. Residuals of the autoregressive associations were allowed 
to covary.
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Our findings suggest that coordinated specialty care 
programs should target enhancement of motivation to 
support occupational functioning beyond the effects of evi-
dence-based approaches such as supported education and 
employment. Conversely, if the goal is to maintain patient 
motivation, targeting social connection may be fruit-
ful, such as in family-focused interventions. Ultimately, 
enhancing social relationships in the early phases of recov-
ery may lead to distal improvements in occupational func-
tioning through their impact on patient motivation.
Supplementary Material
Supplementary data are available at Schizophrenia 
Bulletin online.
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